Back

Cardiovascular side effects of anti-tumor drugs.

1 September 2019 (11:45 - 12:07)
Organised by:
Congress Presentation Part of: Cardio-Oncology: Novel mechanisms and clinical implications Basic Science, Other ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Javid Moslehi

UCSF Medical Centre, San Francisco (United States of America)

3 More presentations in this session

Presentation thumbnail
The failing heart stimulates tumor growth by circulating factors
Professor R. De Boer (Rotterdam, NL)
Slides Video
Presentation thumbnail
Inflammation as a common risk factor for cancer and cardiovascular disease.
Professor P. Libby (Boston, US)
Slides Video
Presentation thumbnail
Mechanisms and models of anti-cancer drugs.
Associate Professor A. Ghigo (Turin, IT)
Slides Video

Access the full session

Session thumbnail
Cardio-Oncology: Novel mechanisms and clinical implications

The Event

Event poster

ESC Congress 2019

1 September 2019 11:45 CET
You may be interested in
thumbnail
Webinar
How to manage cancer therapy-related cardiovascular toxicity. ESC 2022 Clinical Practice Guidelines - Webinar Series
19 September 2022
thumbnail
Congress Presentation
Anthracycline-induced cardiotoxicity: the role of endothelial dysfunction
29 June 2021
thumbnail
Congress Presentation
Cardiovascular toxicity following modern multiple myeloma therapy in Japanese cohort
1 September 2019
thumbnail
Congress Presentation
Cardiovascular toxicity prediction in breast cancer patients: the HFA/ICOS risk tool in real-world practice
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources